Drug Targeting of Estrogen Receptor Signaling in the Cardiovascular System: Preclinical and Clinical Studies

E-ISSN： 1875-6174|2|2|107-122

ISSN： 1568-0169

Source： Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol.2, Iss.2, 2004-04, pp. : 107-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estrogen receptor- and the cardiovascular system

By Levin E.R.

Trends in Endocrinology and Metabolism, Vol. 13, Iss. 5, 2002-07 ,pp. : 184-185

Elsevier

Access to resources Recommend Favorite

Estrogen, aging and the cardiovascular system

By Stice James P Lee Jennifer S Pechenino Angela S Knowlton Anne A

Future Cardiology, Vol. 5, Iss. 1, 2009-01 ,pp. : 93-103

Future Medicine

Access to resources Recommend Favorite

Estrogen as Neuroprotectant of Nigrostriatal Dopaminergic System: Laboratory and Clinical Studies

By Dluzen Dean E. Horstink Martin W. I. M.

Endocrine Journal, Vol. 21, Iss. 1, 2003-06 ,pp. : 67-76

Humana Press, Inc

Access to resources Recommend Favorite

Hormone Replacement Therapy, Selective Estrogen Receptor Modulators, and Tissue-Specific Compounds: Cardiovascular Effects and Clinical Implications

By Vogelvang Tatjana E. Marius J. van der Mooren Mijatovic Velja

Treatments in Endocrinology, Vol. 3, Iss. 2, 2004-01 ,pp. : 105-115

Adis International

Access to resources Recommend Favorite

Clinical Relevance of Estrogen Receptor Variants in Breast Cancer

By Wiltschke C. Fuqua S.A.W.

Trends in Endocrinology and Metabolism, Vol. 6, Iss. 3, 1995-04 ,pp. : 77-82

Elsevier

Access to resources Recommend Favorite